Microfluidic modelling of the tumor microenvironment for anti-cancer drug development

M Shang, RH Soon, CT Lim, BL Khoo, J Han - Lab on a Chip, 2019 - pubs.rsc.org
Cancer is the leading cause of death worldwide. The complex and disorganized tumor
microenvironment makes it very difficult to treat this disease. The most common in vitro drug …

Breast cancer models: Engineering the tumor microenvironment

G Bahcecioglu, G Basara, BW Ellis, X Ren, P Zorlutuna - Acta biomaterialia, 2020 - Elsevier
The mechanisms behind cancer initiation and progression are not clear. Therefore,
development of clinically relevant models to study cancer biology and drug response in …

Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing

X Yang, K Li, X Zhang, C Liu, B Guo, W Wen, X Gao - Lab on a Chip, 2018 - pubs.rsc.org
Organ-on-a-chip technology can simulate the physiological and pathological
microenvironment of tissues and organs in vitro, thus offering the potential of dispensing with …

[HTML][HTML] Engineering prostate cancer in vitro: what does it take?

A Buskin, E Scott, R Nelson, L Gaughan, CN Robson… - Oncogene, 2023 - nature.com
A key challenge in the clinical management and cause of treatment failure of prostate cancer
(PCa) is its molecular, cellular and clinical heterogeneity. Modelling systems that fully …

Extracellular matrix remodeling and stiffening modulate tumor phenotype and treatment response

JL Leight, AP Drain, VM Weaver - Annual Review of Cancer …, 2017 - annualreviews.org
Solid tumors are characterized by a remodeled and stiffened extracellular matrix. The
extracellular matrix is not a passive by-product of the tumor, but actively compromises tissue …

Exploring the tumor microenvironment with nanoparticles

L Miao, L Huang - Nanotechnology-Based Precision Tools for the …, 2015 - Springer
Recent developments in nanotechnology have brought new approaches to cancer
diagnosis and therapy. While enhanced permeability and retention effect (EPR) promotes …

The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics

KA Fitzgerald, J Guo, EG Tierney, CM Curtin… - Biomaterials, 2015 - Elsevier
Prostate cancer bone metastases are a leading cause of cancer-related death in men with
current treatments offering only marginally improved rates of survival. Advances in the …

[HTML][HTML] Proteomic profiling of human prostate Cancer-associated fibroblasts (CAF) reveals LOXL2-dependent regulation of the tumor microenvironment*[S]

EV Nguyen, BA Pereira, MG Lawrence, X Ma… - Molecular & Cellular …, 2019 - ASBMB
In prostate cancer, cancer-associated fibroblasts (CAF) exhibit contrasting biological
properties to non-malignant prostate fibroblasts (NPF) and promote tumorigenesis …

Preclinical models of prostate cancer: patient-derived xenografts, organoids, and other explant models

GP Risbridger, R Toivanen… - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Prostate cancer remains a lethal disease. Preclinical cancer models that accurately
represent the tumors of the patients they are intended to help are necessary to test potential …

In vitro modeling of mechanics in cancer metastasis

A Malandrino, RD Kamm… - ACS biomaterials science …, 2018 - ACS Publications
In addition to a multitude of genetic and biochemical alterations, abnormal morphological,
structural, and mechanical changes in cells and their extracellular environment are key …